Frontier Biotechnologies Inc. (SHA:688221)
China · Delayed Price · Currency is CNY 15.54
+0.64 (4.30%)
At close: Sep 18, 2025
Frontier Biotechnologies Market Cap
Frontier Biotechnologies has a market cap or net worth of 5.82 billion as of September 18, 2025. Its market cap has increased by 208.33% in one year.
Market Cap
5.82B
Enterprise Value
5.43B
Revenue
137.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.54
Market Cap Chart
Since October 28, 2020, Frontier Biotechnologies's market cap has decreased from 10.76B to 5.82B, a decrease of -45.90%. That is a compound annual growth rate of -11.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 5.82B | 59.22% |
| Dec 31, 2024 | 3.66B | -1.61% |
| Dec 29, 2023 | 3.72B | -42.53% |
| Dec 30, 2022 | 6.47B | -3.33% |
| Dec 31, 2021 | 6.69B | -3.43% |
| Dec 31, 2020 | 6.93B | -35.64% |
| Oct 28, 2020 | 10.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 460.78B |
| WuXi AppTec | 310.76B |
| Shenzhen Mindray Bio-Medical Electronics | 289.77B |
| Sichuan Biokin Pharmaceutical | 143.33B |
| Shanghai United Imaging Healthcare | 125.45B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.55B |
| Aier Eye Hospital Group | 118.98B |
| Yunnan Baiyao Group Co.,Ltd | 104.72B |